Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul R Skolnik

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Pharmacotherapy|March 5, 2004
Enfuvirtide, a new fusion inhibitor for therapy of human immunodeficiency virus infectionHélène Hardy, Paul R Skolnik
AIDS Patient Care and Stds|May 19, 2006
Approaching the CDC's guidelines on the HIV testing of inpatients: physician-referral versus nonreferral-based testingJeffrey L Greenwald, Jonathan Hall, Paul R Skolnik
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|January 19, 2012
A collaborative awareness system for chronic disease medication adherence applied to HIV infectionJohn O Moore, Helene Hardy, Paul R Skolnik, et al.
The American Journal of Gastroenterology|January 28, 2010
A practical guide to vaccinating the inflammatory bowel disease patientSharmeel K Wasan, Stacey E Baker, Paul R Skolnik, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 28, 2002
Stimulation of peroxisome proliferator-activated receptors alpha and gamma blocks HIV-1 replication and TNFalpha production in acutely infected primary blood cells, chronically infected U1 cells, and alveolar macrophages from HIV-infected subjectsPaul R Skolnik, Mohammed F Rabbi, Jean-Marie Mathys, et al.
Public Health Reports (Washington, D.C. : 1974)|October 3, 2008
Patient risks, outcomes, and costs of voluntary HIV testing at five testing sites within a medical centerSupriya D Mehta, Jonathan Hall, Jeffrey L Greenwald, et al.
Mededpublish (2016)|January 5, 2026
Virtual Team-Based Mentorship: Fostering Knowledge Acquisition, Career Advancement, and ConnectednessSarah M Harendt, Hannah Q Karp, Mariah J Rudd, et al.
Journal of Virology|June 6, 2008
Human immunodeficiency virus infection alters tumor necrosis factor alpha production via Toll-like receptor-dependent pathways in alveolar macrophages and U1 cellsMarlynne Q Nicol, Jean-Marie Mathys, Albertina Pereira, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|March 3, 2007
Adult and pediatric emergency department sexually transmitted disease and HIV screening: programmatic overview and outcomesSupriya D Mehta, Jonathan Hall, Sheryl B Lyss, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 15, 2005
Atazanavir: effects on P-glycoprotein transport and CYP3A metabolism in vitroElke S Perloff, Su X Duan, Paul R Skolnik, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Pharmacotherapy|March 5, 2004
Enfuvirtide, a new fusion inhibitor for therapy of human immunodeficiency virus infectionHélène Hardy, Paul R Skolnik
AIDS Patient Care and Stds|May 19, 2006
Approaching the CDC's guidelines on the HIV testing of inpatients: physician-referral versus nonreferral-based testingJeffrey L Greenwald, Jonathan Hall, Paul R Skolnik
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|January 19, 2012
A collaborative awareness system for chronic disease medication adherence applied to HIV infectionJohn O Moore, Helene Hardy, Paul R Skolnik, et al.
The American Journal of Gastroenterology|January 28, 2010
A practical guide to vaccinating the inflammatory bowel disease patientSharmeel K Wasan, Stacey E Baker, Paul R Skolnik, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 28, 2002
Stimulation of peroxisome proliferator-activated receptors alpha and gamma blocks HIV-1 replication and TNFalpha production in acutely infected primary blood cells, chronically infected U1 cells, and alveolar macrophages from HIV-infected subjectsPaul R Skolnik, Mohammed F Rabbi, Jean-Marie Mathys, et al.
Public Health Reports (Washington, D.C. : 1974)|October 3, 2008
Patient risks, outcomes, and costs of voluntary HIV testing at five testing sites within a medical centerSupriya D Mehta, Jonathan Hall, Jeffrey L Greenwald, et al.
Mededpublish (2016)|January 5, 2026
Virtual Team-Based Mentorship: Fostering Knowledge Acquisition, Career Advancement, and ConnectednessSarah M Harendt, Hannah Q Karp, Mariah J Rudd, et al.
Journal of Virology|June 6, 2008
Human immunodeficiency virus infection alters tumor necrosis factor alpha production via Toll-like receptor-dependent pathways in alveolar macrophages and U1 cellsMarlynne Q Nicol, Jean-Marie Mathys, Albertina Pereira, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|March 3, 2007
Adult and pediatric emergency department sexually transmitted disease and HIV screening: programmatic overview and outcomesSupriya D Mehta, Jonathan Hall, Sheryl B Lyss, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 15, 2005
Atazanavir: effects on P-glycoprotein transport and CYP3A metabolism in vitroElke S Perloff, Su X Duan, Paul R Skolnik, et al.
Pageof 4